Your body already has a built-in system for clearing fibrin, the protein mesh that forms blood clots. The process is called fibrinolysis, and it runs constantly, dissolving clots once they have done their job. The real question behind “how to get rid of fibrin” is usually about what to do when that system falls behind, whether because of aging, chronic inflammation, surgery, or a condition like Long COVID that produces stubborn fibrin deposits. Supporting your body’s own clot-clearing machinery involves a mix of lifestyle choices, and in some cases supplements or medical treatments, but the details matter more than most online advice lets on.
How Your Body Breaks Down Fibrin on Its Own
Fibrin forms when your clotting system converts a soluble blood protein called fibrinogen into an insoluble mesh that plugs wounds. Once healing is underway, the body needs to dismantle that mesh so blood can flow normally again. It does this through fibrinolysis, a tightly regulated process in which plasminogen activators convert a precursor protein, plasminogen, into plasmin. Plasmin is the enzyme that actually chews through fibrin strands and breaks the clot apart.1PubMed Central. Fibrinolysis: an illustrated review
Two types of plasminogen activators drive this process. Tissue-type plasminogen activator (tPA) is released mainly by cells lining blood vessels, and it works best when it is bound directly to fibrin, which means it tends to activate plasmin right where a clot sits. Urokinase-type plasminogen activator works in a broader range of tissues. On the other side, inhibitors like plasminogen activator inhibitor-1 (PAI-1) act as brakes, preventing the system from dissolving clots too fast or destroying clots you still need.2PubMed Central. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions
When this system is balanced, fibrin forms where it is needed, stays long enough to support healing, and then gets cleared. Problems arise when the balance tips. Too much PAI-1, too little tPA, chronic inflammation, or structurally abnormal fibrin can all slow the clearance side, letting fibrin accumulate in places it does not belong.
Exercise Is the Strongest Everyday Lever
If there is one thing you can do today to help your body clear fibrin more efficiently, it is regular moderate-intensity exercise. Physical activity boosts tPA release from the cells lining your blood vessels while simultaneously lowering PAI-1, the main brake on fibrinolysis.3PubMed. Blood hemostasis in exercise and training The net effect is that your clot-dissolving capacity goes up.
This is not a theoretical benefit. In a study of stroke patients, a single bout of walking increased tPA activity by about 79% and decreased PAI-1 activity by roughly 18%. An hour after the walk ended, tPA was still elevated by over 40% and PAI-1 was still about 25% lower than baseline.4PubMed. A single bout of walking exercise enhances endogenous fibrinolysis in stroke patients That is a meaningful shift from something as simple as a walk.
A systematic review of lifestyle factors and blood clotting found that regular moderate-intensity exercise programs enhance fibrinolytic capacity overall.5Archives of Internal Medicine. Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review Intensity matters, though. Moderate exercise appears to boost fibrinolysis without also ramping up coagulation, which is what you want. Very heavy, exhaustive exercise activates both systems at once, which partly cancels out the benefit.3PubMed. Blood hemostasis in exercise and training So a brisk daily walk or a moderate cycling session does more for fibrin clearance than an occasional extreme workout.
Fibrinolytic Enzymes You Can Take Orally
Several enzyme supplements are marketed as fibrin-busters. The three you will encounter most often are nattokinase, lumbrokinase, and bromelain. Each has real fibrinolytic activity in lab studies, but the practical picture is more complicated than supplement labels suggest.
Nattokinase
Nattokinase is a protein produced by bacteria during the fermentation of soybeans into the Japanese food natto. It has been studied as an oral clot-dissolving agent and is recognized for fibrinolytic activity.6PubMed Central. Nattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease In lab settings, nattokinase can break down fibrin directly. The open question is how much of that activity survives digestion and reaches the bloodstream in meaningful concentrations. Some human studies show effects on blood markers like D-dimer and fibrinogen levels, but large, definitive trials are still lacking. Nattokinase is widely available as a supplement and is generally well tolerated, but it carries real risks for certain people, which we will get to shortly.
Lumbrokinase
Lumbrokinase is a group of fibrinolytic enzymes extracted from earthworms, specifically species like Eisenia fetida. These enzymes are recognized as agents that can help break down fibrin and address conditions associated with abnormal clotting.7PubMed Central. Recombinant protein production of earthworm lumbrokinase for potential antithrombotic application In lab tests, recombinant forms of lumbrokinase have dissolved blood clots, with one study reporting around 66% clot lysis at higher concentrations in vitro.8PLoS ONE. Cloning, Expression and Characterization of a Gene from Earthworm Eisenia fetida Encoding a Blood-Clot Dissolving Protein Lumbrokinase has a longer history of clinical use in parts of East Asia than in Western medicine, and like nattokinase, it still needs larger controlled trials to establish clear dosing guidelines and efficacy for specific conditions.
Bromelain
Bromelain, a protease extracted from pineapple stems, has documented fibrinolytic and anti-inflammatory properties in both lab and animal studies.9Hindawi / Biotechnology Research International. Properties and therapeutic application of bromelain: a review What sets bromelain apart in the bioavailability conversation is a study in healthy men that detected intact, biologically active bromelain in the bloodstream after oral dosing. At 3 grams per day, plasma concentrations reached up to 5,000 picograms per milliliter by 48 hours, and the enzyme retained at least partial proteolytic activity in the blood.10PubMed. Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake That is a small amount, but it is real, undegraded enzyme in circulation. The finding confirms that at least some oral enzymes survive the gut and enter the blood in active form, which is a prerequisite for any systemic fibrin-clearing effect.
When Fibrin Gets Stubborn
Not all fibrin is equally easy to dissolve. Under certain conditions, fibrin can fold into a structurally different form that resists the normal breakdown process. Research over the past few years has identified “amyloid” fibrin microclots in the blood of people with Long COVID. These deposits are anomalous, resistant to fibrinolysis compared to normal fibrin, and can persist even after attempts to dissolve them enzymatically.11PubMed Central. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin These microclots can trap other proteins and may trigger autoantibody production, which could explain some of the lingering symptoms people experience after COVID infection.12Biochemical Journal. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
The stubborn nature of these microclots matters for anyone trying to “get rid of fibrin.” Normal fibrinolysis may not be enough when fibrin has shifted into an amyloid-like state. Lab experiments found that even after enzymatic treatment designed to break down proteins, the microclot deposits in Long COVID plasma persisted and required a second round of treatment before they dissolved.11PubMed Central. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin This resistance to breakdown partly explains why some people feel unwell for months after an infection and why simply taking a fibrinolytic supplement may not resolve the issue on its own.
The structural reason fibrin can become resistant connects to how its protein chains change shape under stress. Under mechanical force, fibrin’s coiled-coil regions can convert from one protein structure to another, more aggregated form that bundles fibers together and makes them harder to disassemble.13Biophysical Journal. Force-Induced α-Helix to β-Sheet Transition in Fibrin Clots Inflammation and certain disease states may drive a similar kind of structural change, producing fibrin that the body’s normal enzymatic toolkit struggles to process.
Medical Treatments That Target Fibrin
When fibrin accumulation becomes a medical emergency, like a stroke or heart attack caused by a clot, doctors use pharmaceutical-grade thrombolytics. The most well known is recombinant tPA (alteplase), which is essentially a concentrated version of the enzyme your body already makes. Administered intravenously, it activates plasminogen directly at the clot site and can restore blood flow within minutes. These drugs are powerful and effective, but they carry a significant risk of bleeding, which is why they are reserved for acute, life-threatening situations in hospital settings and are not something you take at home.
A different approach focuses on preventing new fibrin from forming rather than dissolving what is already there. Experimental work on a compound called GPRP-dextran conjugate illustrates this strategy. The compound mimics a natural binding site on fibrin and competitively blocks the molecular interactions that let fibrin monomers assemble into a mesh. In lab tests, it suppressed fibrin polymerization in a dose-dependent way and shifted the equilibrium toward dissolving existing fibrin, all without completely shutting down clotting.14Circulation. Inhibition of Fibrin Formation by the GPRP–Dextran Conjugate: A New Approach to Safe Anticoagulation This kind of targeted approach is still in early research stages, but it represents where the field is heading: selectively reducing fibrin without the bleeding risks of current drugs.
Safety Risks That Are Easy to Underestimate
The supplements and strategies discussed above are not risk-free, and the danger increases sharply if you are on blood-thinning medications or have certain medical conditions. A case report documented what happened when a patient with a mechanical heart valve stopped taking warfarin and substituted nattokinase. After nearly a year, the patient developed a blood clot on the prosthetic valve and required repeat open-heart surgery.15PubMed Central. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis Nattokinase, whatever its fibrinolytic properties, is not a replacement for prescription anticoagulants when your life depends on clot prevention.
Even without a mechanical valve, combining fibrinolytic supplements with anticoagulants like warfarin, direct oral anticoagulants, or antiplatelet drugs like aspirin can tip the balance too far toward bleeding. Bruising, nosebleeds, and gastrointestinal bleeding are all possible. If you are considering nattokinase, lumbrokinase, or bromelain and you take any blood-thinning medication, talk to your doctor first. The same applies if you have a bleeding disorder, are scheduled for surgery, or are pregnant.
How Aging Tilts the Balance Toward Fibrin Buildup
As you get older, the fibrinolytic system gradually loses ground. PAI-1 levels tend to rise with age, directly slowing down the conversion of plasminogen to plasmin.2PubMed Central. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions At the same time, aging promotes what researchers describe as a hypofibrinolytic environment through several overlapping mechanisms: endothelial dysfunction (the vessel lining works less well), chronic low-grade inflammation, cellular senescence, and structural changes to fibrin itself that make clots harder to dissolve.16SpringerLink (Geroscience). Functional fibrinolysis in older adults: clinical relevance and implications for personalised anticoagulation
This age-related shift helps explain why cardiovascular events become more common later in life and why older adults may benefit more from strategies that support fibrinolysis, particularly exercise. It also means that the “default” level of fibrin in your blood is not static across your lifetime. What your body cleared effortlessly at 30 may accumulate more readily at 65, even without any new disease. Maintaining the lifestyle factors that support fibrinolysis becomes more important, not less, as you age.
Your Fibrinolytic Clock Runs on a Daily Cycle
Fibrinolysis is not constant throughout the day. Your body’s clot-dissolving activity follows a circadian rhythm, driven primarily by fluctuations in tPA and PAI-1. These two components move in opposite directions over a 24-hour cycle: when PAI-1 is high, tPA activity is low, and vice versa.17PubMed. Circadian variation of fibrinolytic activity in blood PAI-1 levels peak in the early morning, which means fibrinolytic capacity is at its lowest point around the time most people wake up. By afternoon, the balance shifts: PAI-1 drops and tPA-driven fibrinolysis ramps up.
This daily pattern has practical consequences. The morning dip in fibrinolysis is one reason heart attacks and strokes cluster disproportionately in the early morning hours. It also means that the timing of exercise could matter, at least in theory. An afternoon walk may coincide with a period when your body is already primed for higher fibrinolytic activity, potentially amplifying the benefit. That said, any exercise is better than no exercise regardless of timing, and no study has definitively shown that scheduling your workout for the afternoon reduces clot risk more than a morning session does.
D-Dimer Testing and What It Actually Tells You
If you are concerned about excess fibrin in your body, D-dimer is the lab test most commonly used to get an indirect picture. D-dimer is a fragment left over when plasmin breaks down cross-linked fibrin. A normal D-dimer level suggests that there is not a significant amount of active clot formation and breakdown happening. An elevated D-dimer means more fibrin is being formed and dissolved than usual, which can indicate anything from a blood clot to recent surgery to infection to pregnancy.18PubMed. The D-dimer assay
D-dimer is routinely used to rule out venous thromboembolism, including deep vein thrombosis and pulmonary embolism.19PubMed. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications A low result is quite reliable for saying “you probably do not have a dangerous clot right now.” But an elevated result is far less specific. Many things raise D-dimer, including advanced age, inflammation, liver disease, and even vigorous exercise. So a high D-dimer does not necessarily mean you have a fibrin problem that needs treatment. It means further investigation is warranted. If you are tracking fibrin-related concerns, especially after a COVID infection or in the context of a clotting disorder, D-dimer can be useful as one piece of the puzzle alongside clinical symptoms and imaging studies.
Fibrin Beyond Blood Clots
Fibrin does not only show up inside blood vessels. After surgery, abnormal fibrous bands called adhesions can form between organs or between organs and surrounding tissue. These are essentially misplaced healing responses where fibrin deposition during the wound-repair process leads to permanent scar-like connections. Postsurgical adhesions are common complications that affect millions of patients worldwide and can cause chronic pain, bowel obstruction, and fertility problems.20PubMed Central. Clinical Implications of Postsurgical Adhesions and Fibrosis: The Role of Vitamin C in Prevention and Control
Addressing this type of fibrin is a different challenge from dissolving a blood clot. Adhesions are structural tissue, not active thrombus, and by the time they are established, they are no longer made of fresh fibrin that plasmin can easily digest. Surgical lysis (physically cutting the adhesions) is the primary treatment, though researchers are exploring whether anti-inflammatory and antifibrotic agents applied during or after surgery might prevent them from forming in the first place. The distinction is worth keeping in mind: “getting rid of fibrin” means very different things depending on whether you are talking about circulating microclots, an acute thrombus, or established scar tissue between your organs.
Putting a Strategy Together
For most people who are not dealing with a diagnosed clotting disorder or an acute medical event, supporting your body’s own fibrinolytic system is the most practical and safest approach. Regular moderate exercise has the strongest evidence base and works through the body’s native tPA-PAI-1 system. Supplements like nattokinase and bromelain have plausible mechanisms and some supporting data, but they are not substitutes for medical treatment when real clotting pathology is present. Staying hydrated, managing chronic inflammation through diet and weight management, and avoiding prolonged immobility all support healthy circulation and, by extension, fibrin turnover.
If you suspect you have a fibrin-related problem, whether due to Long COVID symptoms, a history of blood clots, or recovery from surgery, a conversation with your doctor about D-dimer testing and appropriate treatment is the right starting point. The answer to “how do I get rid of fibrin” is not a single supplement or hack. It is understanding that fibrin clearance is a dynamic biological process you can influence at multiple levels, from the daily walk that boosts tPA to the medical therapies reserved for when the system is overwhelmed.